epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove azelastine ophthalmic
    generic
  • remove Contrave
    naltrexone/ bupropion hydrochloride
  • remove Gas-X Maximum Strength
    simethicone
  • remove Trelegy Ellipta
    fluticasone furoate/ umeclidinium/ vilanterol inhaled

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Contrave (naltrexone/ bupropion hydrochloride) + Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol inhaled)

Monitor/Modify Tx


bupropion + vilanterol inhaled

monitor BP, HR: combo may incr. risk of HTN, other cardiovascular adverse effects (additive effects)

Additional Considerations

Smiley face Smiley face bupropion in Contrave

caution advised with concomitant drugs if smoking cessation use; dose adjustments may be necessary; smoking cessation may alter pharmacokinetics or pharmacodynamics of certain drugs

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information